New NIH-Funded Center Will Advance the Prevention and Treatment of Kidney Disease
The University will use a $4 million grant from the National Institutes of Health to establish the George M. O’Brien Kidney Center at Yale.
The five-year grant from the National Institute of Diabetes and Digestive and Kidney Diseases will help fund three new research cores to provide renal investigators both at Yale and across the country with access to highly specialized services not otherwise routinely available to support their research, says Dr. Peter S. Aronson, the C.N.H. Long Professor of Internal Medicine, professor of cellular and molecular physiology, and director of the Kidney Center.
“The overall goal of the George M. O’Brien Kidney Center at Yale is to facilitate translational and clinical research that will advance the prevention and treatment of kidney diseases,” Aronson says.
The Renal Physiology Core will provide a range of specialized services for assessment of renal function in animal models of kidney disease. The Mouse Genetics and Cell Line Core will enable scientists to generate unique mouse models of human disease. The Human Genetics and Clinical Research Core will provide high technology services to enhance translational studies in kidney disease, particularly in the area of human genetics.
In addition, a pilot grant program will be established to provide initial project funding for young investigators, to attract new investigators into the field of kidney disease research, and to foster translational and clinical studies directly related to kidney diseases.